
About Mangalam Organics Limited
Data last updated:
Mangalam Organics Limited is a public limited company based in Khopoli, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 03 July 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24110MH1981PLC024742. Its GSTIN is 27AAACD1849B1Z2 (Maharashtra). The company holds 17 GST registrations, of which 7 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 514418 and NSE: MANORG.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹8.56 Cr. It was formerly known as Dujodwala Products Limited. It is led by directors including Pannkaj Dujodwala (Managing Director) and Kamalkumar Ramgopal Dujodwala.
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Kumbhivali Village Savroli Kharpada Road Taluka Khalapur, Khopoli, Maharashtra, India – 410203.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹622.57 Cr, a growth of 17.5% compared to the previous year. For the same year it recorded a net profit of ₹25.81 Cr (net margin 4.1%) and EBITDA of ₹84.32 Cr (EBITDA margin 13.5%). The net worth stands at ₹318.59 Cr (up 8.7% YoY). Total assets are valued at ₹682.19 Cr (up 20% YoY).
The company has about 254 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand: Mangalam Organics. As per MCA filings, the company has open charges of ₹705.41 Cr and satisfied charges of ₹175.69 Cr on record. Court records list 154 cases involving the company, including 124 filed by the company and 30 filed against it; 49 cases are pending. The company has 37 deals on record (23 market trades, 13 secondary share transfers, 1 funding round), with disclosed funding of ₹80.1 Lakh; the latest was in June 2026. Its 10 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Ganga Rasayanie Pvt Ltd with revenue of ₹550.14 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mangalamorganics.com.
Company details
CIN history
Mangalam Organics has one previous CIN (Corporate Identification Number): L24110MH1981PTC024742. The current CIN is L24110MH1981PLC024742, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24110MH1981PLC024742 | Current |
| L24110MH1981PTC024742 | Previous |
Contact details
Mangalam Organics Limited's registered office is in Khopoli, Maharashtra. Its website is mangalamorganics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKumbhivali Village Savroli Kharpada Road Taluka Khalapur, Khopoli, Maharashtra, India – 410203
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Mangalam Organics Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mangalam Organics operates one associated brand: Mangalam Organics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pine chemicals, synthetic resins, and camphor products are manufactured. | mangalamorganics.com |
Business activity
The main business activity of Mangalam Organics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mangalam Organics Limited, buy the company report.
Financials of Mangalam Organics Limited
FY 2025-26 filings availableMangalam Organics Limited reported revenue of ₹622.57 Cr (up 17.5% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 623 | 530 | 494 | 493 | 491 | 338 | 375 |
| Revenue growth | +17.5% | +7.4% | +0.2% | +0.4% | +45.1% | -9.7% | - |
| EBITDA | 84.32 | 58.58 | 38.67 | (2.77) | 90.98 | 128 | 76.06 |
| EBITDA margin | +13.5% | +11.1% | +7.8% | -0.6% | +18.5% | +37.8% | +20.3% |
| Profit before tax | 33.30 | 16.61 | 3.99 | (33.76) | 73.20 | 114 | 62.90 |
| Net profit | 25.81 | 12.59 | 4.42 | (27.21) | 53.74 | 84.88 | 55.75 |
| Net profit margin | +4.2% | +2.4% | +0.9% | -5.5% | +11.0% | +25.1% | +14.9% |
| EPS (₹) | 30.07 | 14.71 | 5.15 | (31.79) | 62.75 | 99.10 | 55.97 |
| Balance sheet | |||||||
| Total assets | 682 | 569 | 457 | 469 | 519 | 279 | 191 |
| Net worth | 319 | 293 | 281 | 276 | 304 | 252 | 168 |
| Total debt | 359 | 272 | 173 | 190 | 212 | 24.35 | 20.23 |
| Cash & bank | 2.59 | 1.01 | 2.19 | 1.45 | 1.41 | 34.40 | 0.69 |
| Net working capital | 350 | 264 | 197 | 226 | 308 | 161 | 85.76 |
| Cash flow | |||||||
| Cash from operations | 0.92 | (7.84) | 73.18 | 76.92 | (84.10) | 26.28 | 93.33 |
| Cash from investing | (60.05) | (67.05) | (39.51) | (40.78) | (99.53) | (28.15) | (59.30) |
| Cash from financing | 59.79 | 73.63 | (33.01) | (35.58) | 183 | 2.27 | (35.92) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 179 | 154 | 164 | 158 | 147 | 150 | 124 | 138 |
| Revenue growth (YoY) | +22.2% | +2.6% | +32.6% | +14.3% | +24.2% | - | - | - |
| Other income | 0.08 | (19.83) | 0.00 | 20.54 | 4.04 | 0.01 | 0.01 | 0.11 |
| EBITDA | 22.20 | 46.65 | 19.30 | (3.24) | 21.61 | 19.67 | 15.71 | 12.34 |
| EBITDA margin | +12.4% | +30.4% | +11.7% | -2.0% | +14.7% | +13.1% | +12.7% | +8.9% |
| Depreciation | 6.16 | 10.47 | 5.75 | 6.13 | 5.22 | 5.53 | 5.05 | 5.19 |
| Interest | 7.42 | 7.39 | 8.07 | 7.00 | 5.74 | 7.55 | 5.83 | 4.16 |
| Profit before tax | 8.70 | 8.96 | 5.48 | 4.17 | 14.69 | 6.60 | 4.84 | 3.10 |
| Tax | 1.43 | 2.97 | 1.15 | 0.97 | 2.45 | 1.46 | 1.20 | 0.95 |
| Net profit | 7.27 | 5.99 | 4.33 | 3.20 | 12.24 | 5.14 | 3.64 | 2.15 |
| EPS (₹) | 8.49 | 6.56 | 5.07 | 3.73 | 14.28 | 5.92 | 4.25 | 2.48 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 501 | 410 | 405 | 467 | 491 | 338 | 375 |
| Revenue growth | +22.2% | +1.1% | -13.2% | -4.9% | +45.1% | -9.7% | - |
| EBITDA | 48.59 | 48.07 | 34.42 | (3.41) | 91.21 | 128 | 76.06 |
| EBITDA margin | +9.7% | +11.7% | +8.5% | -0.7% | +18.6% | +37.8% | +20.3% |
| Profit before tax | 17.69 | 10.69 | 3.47 | (31.34) | 73.85 | 114 | 62.90 |
| Net profit | 8.83 | 7.77 | 4.15 | (25.40) | 54.31 | 84.86 | 55.75 |
| Net profit margin | +1.8% | +1.9% | +1.0% | -5.4% | +11.1% | +25.1% | +14.9% |
| EPS (₹) | 16.01 | 9.06 | 4.85 | (29.66) | 63.39 | 99.09 | 55.97 |
| Balance sheet | |||||||
| Total assets | 595 | 555 | 448 | 457 | 503 | 279 | 191 |
| Net worth | 303 | 290 | 282 | 278 | 305 | 252 | 168 |
| Total debt | 288 | 263 | 163 | 176 | 196 | 24.29 | 20.23 |
| Cash & bank | 1.48 | 0.36 | 1.07 | 0.96 | 1.12 | 34.40 | 0.69 |
| Net working capital | 343 | 254 | 203 | 221 | 304 | 161 | 85.76 |
| Cash flow | |||||||
| Cash from operations | 30.94 | (46.49) | 54.72 | 65.68 | (84.61) | 26.40 | 93.33 |
| Cash from investing | (31.27) | (29.65) | (26.57) | (31.66) | (82.55) | (28.25) | (59.30) |
| Cash from financing | 0.52 | 75.41 | (28.05) | (33.45) | 166 | 2.24 | (35.92) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 163 | 135 | 122 | 130 | 114 | 104 | 101 | 110 |
| Revenue growth (YoY) | +43.5% | +29.5% | +21.8% | +18.6% | +18.9% | - | - | - |
| Other income | 0.04 | (12.05) | 1.18 | 21.96 | 5.50 | 0.39 | 0.46 | 0.66 |
| Total expenses | 145 | 103 | 110 | 138 | 101 | 89.36 | 86.93 | 99.66 |
| EBITDA | 17.68 | 31.26 | 12.37 | (8.07) | 13.04 | 14.61 | 13.60 | 10.11 |
| EBITDA margin | +10.8% | +23.2% | +10.1% | -6.2% | +11.5% | +14.1% | +13.5% | +9.2% |
| Depreciation | 5.48 | 7.26 | 4.98 | 4.88 | 4.80 | 4.61 | 4.82 | 4.92 |
| Interest | 5.87 | 6.53 | 7.08 | 6.47 | 5.50 | 7.31 | 5.45 | 3.87 |
| Profit before tax | 6.37 | 5.42 | 1.49 | 2.54 | 8.24 | 3.08 | 3.79 | 1.98 |
| Tax | 1.05 | 1.66 | 0.39 | 0.63 | 1.32 | 0.90 | 0.96 | 0.60 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 179 | 154 | 164 | 158 | 147 | 150 | 124 | 138 |
| Revenue growth (YoY) | +22.2% | +2.6% | +32.6% | +14.3% | +24.2% | - | - | - |
| Other income | 0.08 | (19.83) | 0.00 | 20.54 | 4.04 | 0.01 | 0.01 | 0.11 |
| EBITDA | 22.20 | 46.65 | 19.30 | (3.24) | 21.61 | 19.67 | 15.71 | 12.34 |
| EBITDA margin | +12.4% | +30.4% | +11.7% | -2.0% | +14.7% | +13.1% | +12.7% | +8.9% |
| Depreciation | 6.16 | 10.47 | 5.75 | 6.13 | 5.22 | 5.53 | 5.05 | 5.19 |
| Interest | 7.42 | 7.39 | 8.07 | 7.00 | 5.74 | 7.55 | 5.83 | 4.16 |
| Profit before tax | 8.70 | 8.96 | 5.48 | 4.17 | 14.69 | 6.60 | 4.84 | 3.10 |
| Tax | 1.43 | 2.97 | 1.15 | 0.97 | 2.45 | 1.46 | 1.20 | 0.95 |
| Net profit | 7.27 | 5.99 | 4.33 | 3.20 | 12.24 | 5.14 | 3.64 | 2.15 |
| EPS (₹) | 8.49 | 6.56 | 5.07 | 3.73 | 14.28 | 5.92 | 4.25 | 2.48 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 623 | 530 | 494 | 493 | 491 | 338 | 375 |
| Revenue growth | +17.5% | +7.4% | +0.2% | +0.4% | +45.1% | -9.7% | - |
| Other income | 4.75 | 0.33 | 0.78 | 0.34 | 1.44 | 1.05 | 1.03 |
| Total expenses | 538 | 471 | 455 | 495 | 400 | 210 | 298 |
| Employee cost | 49.92 | 41.54 | 39.07 | 34.70 | 29.74 | 26.91 | 25.46 |
| EBITDA | 84.32 | 58.58 | 38.67 | (2.77) | 90.98 | 128 | 76.06 |
| EBITDA margin | +13.5% | +11.1% | +7.8% | -0.6% | +18.5% | +37.8% | +20.3% |
| Depreciation | 27.58 | 20.82 | 19.84 | 17.54 | 15.02 | 13.53 | 8.97 |
| Interest | 28.19 | 21.48 | 15.62 | 13.79 | 4.20 | 1.00 | 5.22 |
| Profit before tax | 33.30 | 16.61 | 3.99 | (33.76) | 73.20 | 114 | 62.90 |
| Tax | 7.54 | 4.02 | (0.30) | (6.54) | 19.47 | 29.42 | 14.98 |
| Net profit | 25.81 | 12.59 | 4.42 | (27.21) | 53.74 | 84.88 | 55.75 |
| Net profit margin | +4.2% | +2.4% | +0.9% | -5.5% | +11.0% | +25.1% | +14.9% |
| EPS (₹) | 30.07 | 14.71 | 5.15 | (31.79) | 62.75 | 99.10 | 55.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 8.56 | 8.56 | 8.56 | 8.56 | 8.56 | 8.56 | 8.56 |
| Reserves & surplus | 310 | 285 | 272 | 267 | 296 | 243 | 159 |
| Shareholders' funds (net worth) | 319 | 293 | 281 | 276 | 304 | 252 | 168 |
| Minority interest | 0.00 | 0.00 | (0.11) | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 237 | 199 | 103 | 103 | 150 | 0.02 | 8.82 |
| Unsecured loans | 122 | 73.55 | 70.40 | 87.48 | 61.82 | 24.33 | 11.41 |
| Total debt | 359 | 272 | 173 | 190 | 212 | 24.35 | 20.23 |
| Total liabilities | 682 | 569 | 457 | 469 | 519 | 279 | 191 |
| Assets | |||||||
| Gross block | 496 | 432 | 386 | 349 | 303 | 211 | 179 |
| Net block | 328 | 269 | 244 | 227 | 198 | 121 | 102 |
| Capital work in progress | 0.00 | 26.13 | 4.74 | 1.41 | 7.66 | 0.00 | 3.45 |
| Investments | 0.30 | 0.30 | 0.30 | 0.30 | 0.00 | 0.00 | 0.00 |
| Inventories | 300 | 213 | 136 | 189 | 244 | 106 | 64.71 |
| Sundry debtors | 58.73 | 69.38 | 56.02 | 47.49 | 44.08 | 34.44 | 31.32 |
| Cash & bank balances | 2.59 | 1.01 | 2.19 | 1.45 | 1.41 | 34.40 | 0.69 |
| Loans & advances | 39.08 | 33.84 | 31.23 | 25.22 | 54.89 | 15.29 | 10.15 |
| Total current assets | 401 | 317 | 225 | 264 | 344 | 190 | 107 |
| Total current liabilities | 50.71 | 53.83 | 28.20 | 37.23 | 36.16 | 29.24 | 21.11 |
| Net working capital | 350 | 264 | 197 | 226 | 308 | 161 | 85.76 |
| Total assets | 682 | 569 | 457 | 469 | 519 | 279 | 191 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.48 | 1.74 | 1.08 | 0.51 | 1.04 | 0.65 | 2.53 |
| Net cash from operating activities | 0.92 | (7.84) | 73.18 | 76.92 | (84.10) | 26.28 | 93.33 |
| Net cash from investing activities | (60.05) | (67.05) | (39.51) | (40.78) | (99.53) | (28.15) | (59.30) |
| Net cash from financing activities | 59.79 | 73.63 | (33.01) | (35.58) | 183 | 2.27 | (35.92) |
| Net change in cash | 0.65 | (1.27) | 0.66 | 0.57 | (0.53) | 0.40 | (1.88) |
| Closing cash | 2.59 | 1.01 | 2.19 | 1.45 | 1.41 | 34.40 | 0.69 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +17.5% | +7.4% | +0.2% | +0.4% | +45.1% | -9.7% | - |
| EBITDA growth | +43.9% | +51.5% | +1496.0% | -103.0% | -28.8% | +68.0% | - |
| PBT growth | +100.5% | +316.3% | +9998.0% | - | -36.0% | +81.7% | +9997.0% |
| Net income growth | +105.0% | +184.8% | +116.2% | -150.6% | -36.7% | +52.3% | - |
| Revenue CAGR (3Y) | +8.1% | +2.6% | +13.4% | +9.6% | - | - | - |
| EBITDA CAGR (3Y) | - | -13.7% | -32.9% | - | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +4.1% | +2.4% | +0.9% | -5.5% | +11.0% | +25.1% | +12.8% |
| Return on capital employed | +9.8% | +7.4% | +4.2% | -4.0% | +19.4% | +49.1% | +41.1% |
| Return on net worth | +8.4% | +4.4% | +1.5% | -9.4% | +19.3% | +40.5% | +33.2% |
| Debt / equity | 1.03 | 0.78 | 0.65 | 0.69 | 0.43 | 0.11 | 0.12 |
| Long-term debt / equity | 0.15 | 0.10 | 0.11 | 0.16 | 0.09 | 0.02 | 0.05 |
| Interest cover | 49.68 | 56.89 | 82.95 | -67.90 | 5.53 | 0.88 | 7.78 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.34 | 1.30 | 1.34 | 1.51 | 1.91 | 1.74 | 2.10 |
| Inventory turnover | 2.43 | 3.04 | 3.04 | 2.27 | 2.80 | 3.96 | 5.79 |
| Debtors turnover | 9.72 | 8.45 | 9.54 | 10.76 | 12.50 | 10.29 | 11.96 |
| EPS (₹) | 30.07 | 14.71 | 5.15 | (31.79) | 62.75 | 99.10 | 55.97 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 | 1.50 | 1.00 |
| Book value per share (₹) | 371.94 | 342.30 | 327.70 | 321.90 | 355.04 | 293.86 | 196.04 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 163 | 135 | 122 | 130 | 114 | 104 | 101 | 110 |
| Revenue growth (YoY) | +43.5% | +29.5% | +21.8% | +18.6% | +18.9% | - | - | - |
| Other income | 0.04 | (12.05) | 1.18 | 21.96 | 5.50 | 0.39 | 0.46 | 0.66 |
| Total expenses | 145 | 103 | 110 | 138 | 101 | 89.36 | 86.93 | 99.66 |
| EBITDA | 17.68 | 31.26 | 12.37 | (8.07) | 13.04 | 14.61 | 13.60 | 10.11 |
| EBITDA margin | +10.8% | +23.2% | +10.1% | -6.2% | +11.5% | +14.1% | +13.5% | +9.2% |
| Depreciation | 5.48 | 7.26 | 4.98 | 4.88 | 4.80 | 4.61 | 4.82 | 4.92 |
| Interest | 5.87 | 6.53 | 7.08 | 6.47 | 5.50 | 7.31 | 5.45 | 3.87 |
| Profit before tax | 6.37 | 5.42 | 1.49 | 2.54 | 8.24 | 3.08 | 3.79 | 1.98 |
| Tax | 1.05 | 1.66 | 0.39 | 0.63 | 1.32 | 0.90 | 0.96 | 0.60 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 501 | 410 | 405 | 467 | 491 | 338 | 375 |
| Revenue growth | +22.2% | +1.1% | -13.2% | -4.9% | +45.1% | -9.7% | - |
| Other income | 16.59 | 2.04 | 2.49 | 1.39 | 1.44 | 1.05 | 1.03 |
| Total expenses | 452 | 362 | 371 | 470 | 400 | 210 | 298 |
| Employee cost | 33.91 | 29.68 | 26.72 | 22.70 | 29.63 | 26.91 | 25.46 |
| EBITDA | 48.59 | 48.07 | 34.42 | (3.41) | 91.21 | 128 | 76.06 |
| EBITDA margin | +9.7% | +11.7% | +8.5% | -0.7% | +18.6% | +37.8% | +20.3% |
| Depreciation | 21.92 | 19.13 | 18.82 | 16.64 | 14.91 | 13.53 | 8.97 |
| Interest | 25.57 | 20.29 | 14.62 | 12.68 | 3.89 | 1.00 | 5.22 |
| Profit before tax | 17.69 | 10.69 | 3.47 | (31.34) | 73.85 | 114 | 62.90 |
| Tax | 4.00 | 2.92 | (0.68) | (5.93) | 19.55 | 29.52 | 14.98 |
| Net profit | 8.83 | 7.77 | 4.15 | (25.40) | 54.31 | 84.86 | 55.75 |
| Net profit margin | +1.8% | +1.9% | +1.0% | -5.4% | +11.1% | +25.1% | +14.9% |
| EPS (₹) | 16.01 | 9.06 | 4.85 | (29.66) | 63.39 | 99.09 | 55.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 8.56 | 8.56 | 8.56 | 8.56 | 8.56 | 8.56 | 8.56 |
| Reserves & surplus | 295 | 281 | 274 | 270 | 296 | 243 | 159 |
| Shareholders' funds (net worth) | 303 | 290 | 282 | 278 | 305 | 252 | 168 |
| Secured loans | 264 | 242 | 151 | 163 | 188 | 0.00 | 8.82 |
| Unsecured loans | 23.74 | 20.20 | 12.42 | 13.67 | 7.51 | 24.29 | 11.41 |
| Total debt | 288 | 263 | 163 | 176 | 196 | 24.29 | 20.23 |
| Total liabilities | 595 | 555 | 448 | 457 | 503 | 279 | 191 |
| Assets | |||||||
| Gross block | 404 | 385 | 354 | 326 | 286 | 211 | 179 |
| Net block | 245 | 227 | 214 | 205 | 181 | 121 | 102 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 7.66 | 0.00 | 3.45 |
| Investments | 0.55 | 0.55 | 0.54 | 0.54 | 0.20 | 0.10 | 0.00 |
| Inventories | 273 | 203 | 120 | 172 | 243 | 106 | 64.71 |
| Sundry debtors | 72.19 | 55.19 | 74.25 | 57.60 | 43.95 | 34.44 | 31.32 |
| Cash & bank balances | 1.48 | 0.36 | 1.07 | 0.96 | 1.12 | 34.40 | 0.69 |
| Loans & advances | 37.11 | 31.34 | 29.04 | 22.24 | 51.00 | 15.29 | 10.15 |
| Total current assets | 384 | 290 | 224 | 252 | 339 | 190 | 107 |
| Total current liabilities | 40.72 | 36.00 | 21.50 | 31.84 | 34.57 | 29.28 | 21.11 |
| Net working capital | 343 | 254 | 203 | 221 | 304 | 161 | 85.76 |
| Total assets | 595 | 555 | 448 | 457 | 503 | 279 | 191 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.16 | 0.89 | 0.79 | 0.22 | 1.04 | 0.65 | 2.53 |
| Net cash from operating activities | 30.94 | (46.49) | 54.72 | 65.68 | (84.61) | 26.40 | 93.33 |
| Net cash from investing activities | (31.27) | (29.65) | (26.57) | (31.66) | (82.55) | (28.25) | (59.30) |
| Net cash from financing activities | 0.52 | 75.41 | (28.05) | (33.45) | 166 | 2.24 | (35.92) |
| Net change in cash | 0.19 | (0.73) | 0.11 | 0.56 | (0.82) | 0.40 | (1.88) |
| Closing cash | 1.48 | 0.36 | 1.07 | 0.96 | 1.12 | 34.40 | 0.69 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +22.2% | +1.1% | -13.2% | -4.9% | +45.1% | -9.7% | - |
| EBITDA growth | +1.1% | +39.7% | +1109.4% | -103.7% | -28.7% | +68.1% | - |
| PBT growth | +65.5% | +208.1% | +9998.0% | - | -35.4% | +81.8% | -38.1% |
| Net income growth | +13.6% | +87.2% | +116.3% | -146.8% | -36.0% | +52.2% | - |
| Revenue CAGR (3Y) | +2.4% | -5.8% | +6.2% | +7.6% | +5.0% | +12.0% | +28.5% |
| EBITDA CAGR (3Y) | - | -19.2% | -35.4% | - | -5.7% | +71.8% | +84.8% |
| Profitability & leverage | |||||||
| Net income margin | +2.7% | +1.9% | +1.0% | -5.4% | +11.1% | +25.1% | +12.8% |
| Return on capital employed | +6.8% | +6.2% | +4.0% | -3.9% | +19.9% | +49.2% | +43.1% |
| Return on net worth | +3.0% | +2.7% | +1.5% | -8.7% | +19.5% | +40.5% | +38.6% |
| Debt / equity | 0.93 | 0.74 | 0.61 | 0.64 | 0.40 | 0.11 | 0.24 |
| Long-term debt / equity | 0.09 | 0.08 | 0.08 | 0.11 | 0.07 | 0.02 | 0.05 |
| Interest cover | 95.88 | 70.11 | 93.72 | -63.24 | 5.10 | 0.87 | 7.78 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.27 | 1.11 | 1.19 | 1.53 | 1.98 | 1.74 | 2.52 |
| Inventory turnover | 2.10 | 2.54 | 2.78 | 2.25 | 2.81 | 3.96 | 5.71 |
| Debtors turnover | 7.86 | 6.33 | 6.15 | 9.20 | 12.53 | 10.29 | 10.92 |
| EPS (₹) | 16.01 | 9.06 | 4.85 | (29.66) | 63.39 | 99.09 | 55.97 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 | 1.50 | 1.00 |
| Book value per share (₹) | 353.91 | 338.41 | 329.54 | 324.78 | 355.78 | 293.96 | 196.04 |
To see the full year-wise statements and ratios of Mangalam Organics Limited, buy the company report.
Board of directors of Mangalam Organics Limited
Mangalam Organics has 7 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamalkumar Ramgopal Dujodwala Also directs: Mangalam Brands Private Limited, Mangalam Speciality Chemicals Private Limited, Bhuruka Gases Limited and 5 more | Director | 03 Jul 1981 | 45 Years 3 Months | Current |
| Pannkaj Dujodwala Also directs: Mangalam Brands Private Limited, Mangalam Speciality Chemicals Private Limited, Dujodwala Exports Private Limited and 5 more | Managing Director | 03 Jun 1987 | 39 Years 4 Months | Current |
| Manisha Agarwal | Director | 20 Mar 2020 | 6 Years 7 Months | Current |
| Sidharath Sekhon | Director | 30 Dec 2022 | 3 Years 10 Months | Current |
| Sanjay Bhiva Kadam Also directs: Mangalam Brands Private Limited | Director | 30 Dec 2022 | 3 Years 10 Months | Current |
| Mahesh Lahurao Navathar | Director | 07 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Mangalam Organics Limited is compared with the 10 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mangalam Organics Limitedthis company | ₹622.57 Cr (FY 2026) | ₹25.81 Cr | 4.1% | 17.5% | 254 | Khopoli, Maharashtra, India |
| Ganga Rasayanie Pvt Ltd | ₹550.14 Cr (FY 2024) | 2.0% | Kolkata, West Bengal, India | |||
| Nitta Gelatin India Limited | ₹544.58 Cr (FY 2025) | 0.0% | Ernakulam, Kerala, India | |||
| Palvi Industries Limited | ₹543.65 Cr (FY 2025) | 43.0% | Vadodara, Gujarat, India | |||
| Ivp Ltd | ₹542.57 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Fairchem Organics Limited | ₹539.24 Cr (FY 2025) | -13.0% | Ahmedabad, Gujarat, India | |||
| Sterling Auxiliaries Pvt Ltd | ₹527.08 Cr (FY 2024) | 32.0% | Mumbai, Maharashtra, India | |||
| Saptagir Camphor Private Limited | ₹523.92 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| Parikh Enterprises Private Limited | ₹515.92 Cr (FY 2025) | 79.0% | Ahmedabad, Gujarat, India | |||
| Sigachi Industries Limited | ₹508.76 Cr (FY 2025) | 24.0% | Hyderabad, Telangana, India | |||
| Deepak Novochem Technologies Limited | ₹503.45 Cr (FY 2025) | 56.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Mangalam Organics Limited, buy the company report.
Auditor
Mangalam Organics Limited is audited by NGST & Associates for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NGST & Associates | FY 2025 | 135159W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 58.60%, foreign institutional investors hold 0.00%, domestic institutional investors hold 2.20% and retail and other public shareholders hold 39.20%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 58.60% | 58.60% | 58.60% | 58.60% |
| Public | 41.40% | 41.40% | 41.40% | 41.40% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2026 | 101251112 | Others | ₹50 Cr | Open | |
| 10 Feb 2026 | 101230541 | Axis Bank Limited | ₹12 Cr | Open | |
| 25 Sep 2025 | 101160181 | Yes Bank Limited | ₹48 Cr | Open | |
| 13 Mar 2025 | 101070819 | Others | ₹5 Cr | Open | |
| 03 Mar 2025 | 101069893 | Others | ₹43 Lakh | Open |
To see the full charge records of Mangalam Organics Limited, buy the company report.
Total charge records: 56 View all charges
Deals & funding
Mangalam Organics Limited has 37 deals on record (23 market trades, 13 secondary share transfers, 1 funding round), with disclosed funding of ₹80.1 Lakh; the latest was in June 2026.
Deals on record (5 of 37)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2023 | Market trade | ₹15.03 Cr | Buyer: Graviton Research Capital LLP , XTX Markets LLP , NK Securities Research Private Limited Seller: Graviton Research Capital LLP , XTX Markets LLP , NK Securities Research Private Limited |
| Nov 2021 | Market trade | ₹18.07 Cr | Buyer: Texport Industries Private Limited Seller: J.B.C. International LLP |
| Feb 2020 | Market trade | ₹8.22 Cr | Buyer: an individual Seller: J.B.C. International LLP |
| May 2018 | Secondary share transfer | Undisclosed | Seller: Others Mangalam Organics Limited, Rajasthan Global Securities Private Limited |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Investor Education & Protection Fund Authority, Rajasthan Global Securities Private Limited , an individual Seller: Others Mangalam Organics Limited, 2 individuals |
To see the full deal history of Mangalam Organics Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mangalam Organics Limited has 154 court cases on record: 124 filed by Mangalam Organics, 30 filed against it. 49 cases are pending and 105 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 93 | 13 | 23 |
| High courts | 53 | 12 | 22 |
| Supreme Court | 8 | 5 | 4 |
Cases on record (5 of 154)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Messrs Hme Boilers Private Limited Through Director Vipul Kiritbhai Banker | Pending |
| Bombay High Court | Arbitration matter | Filed against the company by Dorf Ketal Chemicals India Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Dabur India Limited & Anr. | Pending |
| High Court | Court case (COMIP) | Filed by the company against N Ranga Rao and Sons Pvt Ltd | Pending |
| High Court | Court case (COMIP) | Filed by the company against Patanjali Ayurved Ltd A Company | Pending |
To see the full case history of Mangalam Organics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Mangalam Organics Limited was last rated by Crisil on 07 Feb 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 07 Feb 2020 |
To see the full credit ratings and regulatory alerts of Mangalam Organics Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mangalam Organics Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Mangalam Organics has 3 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Mangalam Brands Private Limited | U24100MH2020PTC339492 | |
| Mangalam Speciality Chemicals Private Limited | U24119MH2022PTC377807 | |
| Mangalam Pooja Stores Private Limited | U52609MH2022PTC377049 |
To see the full group structure of Mangalam Organics Limited, buy the company report.
Employees & EPFO
Mangalam Organics Limited has a workforce of 254 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.
GST
Mangalam Organics has 17 GST registrations: 7 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACD1849B1Z2 | Maharashtra | Active | 01 Jul 2017 |
| 07AAACD1849B1Z4 | Delhi | Active | 01 Jul 2017 |
| 19AAACD1849B1ZZ | West Bengal | Active | 01 Jul 2017 |
| 29AAACD1849B1ZY | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mangalam Organics Limited, buy the company report.
Recent activity
Mangalam Organics Limited has 31 board changes on record since 1981: 19 appointments and 12 cessations. The latest: Mahesh Lahurao Navathar was appointed as Director on 07 Feb 2025.
130 earlier events are in the company report.
News
Frequently asked questions
Mangalam Organics is an active public limited company based in Khopoli, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 03 July 1981 (45+ years old) and is registered under CIN L24110MH1981PLC024742. Listed on BSE: 514418 and NSE: MANORG.
Mangalam Organics reported revenue of ₹622.57 Cr for FY 2025-26 (up 17.5% YoY) based on consolidated financials.
Mangalam Organics has 7 current directors:
- Pannkaj Dujodwala - Managing Director
- Kamalkumar Ramgopal Dujodwala - Director
- Manisha Agarwal - Director
- Sidharath Sekhon - Director
- Sanjay Bhiva Kadam - Director
- Mahesh Lahurao Navathar - Director
- Sudarshankumar Saraf - Director
The latest financial statements of Mangalam Organics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 16 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mangalam Organics is 27AAACD1849B1Z2, registered in Maharashtra. The company has 17 GST registrations in all, of which 7 are active and 10 are cancelled or inactive. Other active GSTINs include 07AAACD1849B1Z4 (Delhi), 19AAACD1849B1ZZ (West Bengal), 29AAACD1849B1ZY (Karnataka).
The CIN (Corporate Identification Number) of Mangalam Organics is L24110MH1981PLC024742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Mangalam Organics is a listed company as per MCA records. Its shares are listed on both BSE (code: 514418) and NSE (symbol: MANORG).
Mangalam Organics has 154 court cases on record: 124 filed by the company and 30 filed against it. 49 are pending. Most are in the district courts.
Mangalam Organics was incorporated on 03 July 1981, making it 45+ years old. It is registered with the Registrar of Companies, Mumbai.
Mangalam Organics has 37 deals on record (23 market trades, 13 secondary share transfers, 1 funding round), with disclosed funding of ₹80.1 Lakh; the latest was in June 2026.
The peers of Mangalam Organics by revenue are Ganga Rasayanie Pvt Ltd, Nitta Gelatin India Limited, Palvi Industries Limited, Ivp Ltd, Fairchem Organics Limited and 5 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

